Results 101 to 108 of about 133,636 (108)

Results on double beta decay of 82Se with CUPID-0 Phase I

WORKSHOP ON CALCULATION OF DOUBLE-BETA-DECAY MATRIX ELEMENTS (MEDEX’19), 2019
CUPID-0 is the first neutrinoless double beta decay (0νββ) experiment based on highly enriched scintillating bolometers. It consists in an array of Zn82Se detectors operated at LNGS since 2017.
L. Pagnanini, O. Azzolini, J. Beeman, F. Bellini, M. Beretta, M. Biassoni, C. Brofferio, C. Bucci, S. Capelli, L. Cardani, P. Carniti, N. Casali, D. Chiesa, M. Clemenza, O. Cremonesi, A. Cruciani, I. Dafinei, S. Domizio, F. Ferroni, L. Gironi, A. Giuliani, P. Gorla, C. Gotti, G. Keppel, S. Nagorny, M. Nastasi, S. Nisi, C. Nones, D. Orlandi, M. Pallavicini, L. Pattavina, M. Pavan, G. Pessina, V. Pettinacci, S. Pirrò, S. Pozzi, E. Previtali, A. Puiu, C. Rusconi, K. Schäffner, C. Tomei, M. Vignati, A. Zolotarova   +42 more
semanticscholar   +1 more source

Two comments on double beta decay beyond the mass mechanism

WORKSHOP ON CALCULATION OF DOUBLE-BETA-DECAY MATRIX ELEMENTS (MEDEX’19), 2019
Neutrinoless double beta decay is usually discussed in connection with Majorana neutrino masses. However, it is well-known that many different contributions to the decay amplitude could in principle exist.
M. Hirsch
semanticscholar   +1 more source

[Modern Approach and Successful Experience of Conservative Treatment of Infantile Hemangiomas with Non-Selective Beta-Blocker Propranolol].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny, 2019
The article deals with the actual problem of modern treatment of infant hemangiomas. The accumulated 10-year experience of using propranolol in 512 patients has shown its effectiveness and safety.
N. Kotlukova, I. M. Osmanov, N. Konstantinova, I. Trunina, T. R. Lavrova, E. V. Karelina, A. Grishkin, I. Mosin   +7 more
semanticscholar   +1 more source

Detección de un brote epidémico por Pseudomonas aeruginosa multirresistente productora de metalo-beta-lactamasa

, 2011
A. Jimeno, M. M. Alcalde, A. Blázquez
semanticscholar   +1 more source

Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm.

Science, 2000
X. Ye, S. Al‐Babili, A. Klöti, Jing Zhang, P. Lucca, P. Beyer, I. Potrykus   +6 more
semanticscholar   +1 more source

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

The Lancet, 2012
J. Cohen, A. Coles, Douglas L Arnold, C. Confavreux, E. Fox, H. Hartung, E. Havrdová, Krzysztof W Selmaj, Howard L. Weiner, E. Fisher, Vesna V. Brinar, G. Giovannoni, M. Stojanovic, Bella I Ertik, S. Lake, D. Margolin, M. Panzara, D. Compston   +17 more
semanticscholar   +1 more source

Measuring beta diversity for presence–absence data

, 2003
Patricia Koleff, K. Gaston, J. Lennon
semanticscholar   +1 more source

[The results of an open comparative retrospective trial of the course of multiple sclerosis during treatment with infibeta and other interferon-beta bioanalogues and glatiramer acetate].

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2018
F. Khabirov, T. Khaybullin, E. Granatov, S. Shakirzianova, N. Babicheva, O. S. Kochergina, E. Rakhmatullina, G. Akhmedova, L. Averyanova, M. A. Yakupov, Z. F. Sabirov   +10 more
semanticscholar   +1 more source